Disclosure Summary
- Addressee: The General Manager - Dept. Corporate Services, BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001
Nature of Disclosure and Regulatory Context
This is a regulatory compliance filing submitted to the BSE. The disclosure is made pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019.
Key Factual Content
The company confirms that during the quarter ended March 31, 2026, there was no deviation or variation in the use of proceeds raised from the preferential issue of equity shares and warrants from the objects originally stated in the Notice to shareholders dated August 28, 2025.
A statement of deviation, which states that there is no deviation, is enclosed with the filing. This statement has been duly reviewed by the Audit Committee of the Company.
The document defines 'deviation or variation' for context, which includes:
- (a) Deviation in the objects or purposes for which the funds were raised.
- (b) Deviation in the amount of funds actually utilized compared to original disclosures.
- (c) Change in terms of a contract referred to in the fund-raising documents (e.g., prospectus, letter of offer).
The attached table for reporting deviations is blank, confirming no instances to report.
Signatory and Enclosure
- Enclosure: A statement of deviation (confirming no deviation) is attached.